Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-24 @ 7:51 PM
NCT ID:
NCT04604704
Eligibility Criteria:
Inclusion Criteria:
* Any ethnicity
* Adequate cognitive function to be able to give informed consent
* Technologically competent to complete web forms and perform video calls with the PI
* Positive PCR test (polymerase chain reaction) result for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) 1-4 months before enrollment
* A fatigue score above 9 in the Chalder Fatigue scale upon enrollment
* Willing to fill out regular questionnaires
* Willing to use LDN and NAD patches
Exclusion Criteria:
* Clinically significant kidney, heart, Hepatic impairment as determined by clinical judgement
* Taking opioid analgesics, or undergoing treatment for opioid addiction
* Opioid dependence or withdrawal syndrome
* Known sensitivity to naltrexone
* Suspected or confirmed pregnancy or breastfeeding
* Known issues with using iontophoresis patches
* Active cancers
* Enrolled in another trial
* Current users of LDN or NAD+
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04604704
Study Brief:
Protocol Section:
NCT04604704